Phreesia, Inc. PHR
12.81 USD -0.32 (-2.44%)
At closeNov 11, 2026, 5:05 PM EST
13.00 +0.19 +1.48%
After hours · Nov 11, 5:05 PM ET
12.32 Day range 12.96
8.06 52-week range 23.15
- YTD
- -24.29%
- 1 year
- -43.69%
News
benzinga.com JP Morgan Downgrades Phreesia to Underweight, Announces $13 Price Target JP Morgan analyst Alexei Gogolev downgrades Phreesia (NYSE:PHR) from Neutral to Underweight and announces $13 price target.
businesswire.com Phreesia Sets Release Date for Fiscal Third Quarter 2027 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) will release its fiscal third quarter 2027 financial results after the close of market trading on Wednesday, Dec. 2,…
businesswire.com Phreesia's Sophia Wagner Named to Becker's 2026 List of Health IT & Revenue Cycle Up-and-Comers ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Sophia Wagner named to Becker's 2026 list of Health IT & Revenue Cycle Up-and-Comers.
seekingalpha.com Phreesia: Q3 Must Prove That Growth Can Drive Higher Profitability Phreesia is rated Buy with a $14.8 price target, reflecting undervaluation versus peers and improving profitability. Q2 revenue grew 10.4% YoY to $129.5M, driven by payment solutions, but…
defenseworld.net Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC) National Research (NASDAQ: NRC - Get Free Report) and Phreesia (NYSE: PHR - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two…
benzinga.com Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11 Barclays analyst Glen Santangelo maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $10 to $11.
benzinga.com Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
businesswire.com Phreesia's Michael Rasbury Named to Becker's 2026 List of Rising Stars: Healthcare Leaders Under 40 ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Michael Rasbury, VP of AccessOne Solutions, named to Becker's Hospital Review's 2026 Rising Stars: Healthcare Leaders Under 40 list.
businesswire.com Phreesia Named to TIME's 2026 List of the World's Top HealthTech Companies ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named to TIME's list of the World's Top HealthTech Companies of 2026.…
defenseworld.net Phreesia (NYSE:PHR) General Counsel Allison Hoffman Sells 6,662 Shares of Stock Phreesia, Inc. (NYSE: PHR - Get Free Report) General Counsel Allison Hoffman sold 6,662 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of…
businesswire.com Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's ProviderConnect audiences are now available in the DeepIntent Audience Marketplace.
fool.com Why Phreesia Stock Got Knocked Down Today This added to lingering negative sentiment following the company's latest earnings release. Investors didn't like the fact that it whiffed on earnings.
benzinga.com DA Davidson Maintains Buy on Phreesia, Lowers Price Target to $13 DA Davidson analyst Clark Wright maintains Phreesia (NYSE:PHR) with a Buy and lowers the price target from $14 to $13.- benzinga.com Baird Maintains Neutral on Phreesia, Raises Price Target to $11 Baird analyst Joseph Vruwink maintains Phreesia (NYSE:PHR) with a Neutral and raises the price target from $10 to $11.
fool.com Why Phreesia Stock Tumbled Today Although its net income rose sharply, analysts expected better. On a brighter note, the company slightly topped the consensus pundit estimate for revenue.- benzinga.com Phreesia Files Shelf Prospectus For Offering; Size Not Disclosed https://www.sec.gov/Archives/edgar/data/1412408/000162828026060497/phreesia-sx3asr2026.htm
benzinga.com These Analysts Revise Their Forecasts On Phreesia After Q2 Results Phreesia Inc (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.
benzinga.com These Analysts Revise Their Forecasts On Phreesia After Q2 Results Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10.
benzinga.com Wells Fargo Maintains Equal-Weight on Phreesia, Raises Price Target to $10 Wells Fargo analyst Stan Berenshteyn maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $9 to $10.
seekingalpha.com Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
zacks.com Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
zacks.com Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates Phreesia (PHR) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.01 per share a year ago.
marketbeat.com Phreesia Q2 Earnings Call Highlights Phreesia NYSE: PHR reported second-quarter fiscal 2027 revenue growth and continued profitability expansion, while maintaining its full-year revenue and adjusted EBITDA outlook. The company said it…
benzinga.com Transcript: Phreesia Q2 2027 Earnings Conference Call Phreesia (NYSE:PHR) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million. Nyxoah (NASDAQ:NYXH) shares increased by…- benzinga.com Phreesia Affirms FY2027 Sales Guidance of $510.000M-$520.000M vs $515.008M Est Phreesia (NYSE:PHR) affirms FY2027 sales outlook from $510.000 million-$520.000 million to $510.000 million-$520.000 million vs $515.008 million estimate.
- benzinga.com Phreesia Q2 EPS $0.03 Misses $0.10 Estimate, Sales $129.458M Beat $129.069M Estimate Phreesia (NYSE:PHR) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.10 by 70 percent. This is a 200 percent increase over earnings of $0.01 per share…
businesswire.com Phreesia Announces Second Quarter Fiscal 2027 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026.…
defenseworld.net Deutsche Bank AG Invests $538,000 in Phreesia, Inc. $PHR Deutsche Bank AG bought a new position in shares of Phreesia, Inc. (NYSE: PHR) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
defenseworld.net Contrasting DarioHealth (NASDAQ:DRIO) and Phreesia (NYSE:PHR) Phreesia (NYSE: PHR - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
defenseworld.net Phreesia, Inc. $PHR Stake Lessened by Dimensional Fund Advisors LP Dimensional Fund Advisors LP lessened its holdings in Phreesia, Inc. (NYSE: PHR) by 22.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and…
defenseworld.net Phreesia (NYSE:PHR) Shares Gap Up – Here’s Why Phreesia, Inc. (NYSE: PHR - Get Free Report)'s stock price gapped up before the market opened on Friday. The stock had previously closed at $11.42, but opened at $12.60. Phreesia shares last traded…- benzinga.com Truist Securities Maintains Hold on Phreesia, Raises Price Target to $12 Truist Securities analyst Jailendra Singh maintains Phreesia (NYSE:PHR) with a Hold and raises the price target from $11 to $12.
- benzinga.com Citigroup Maintains Neutral on Phreesia, Raises Price Target to $12 Citigroup analyst Daniel Grosslight maintains Phreesia (NYSE:PHR) with a Neutral and raises the price target from $10 to $12.
- benzinga.com Canaccord Genuity Maintains Buy on Phreesia, Lowers Price Target to $16 Canaccord Genuity analyst Richard Close maintains Phreesia (NYSE:PHR) with a Buy and lowers the price target from $22 to $16.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com Market-Moving News for May 28th SNOW: 38% | Snowflake shares are trading higher after the company reported better-than-expected Q1 financial results. Also, the company announced it signed a multi-year strategic collaboration…
benzinga.com Why Phreesia Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Other gainers include Snowflake, Genius Group, and Astrotech.- benzinga.com Phreesia Q1 2027 Earnings Call Transcript
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com Phreesia Affirms FY2027 Sales Guidance of $510.000M-$520.000M vs $515.698M Est Phreesia (NYSE:PHR) affirms FY2027 sales outlook from $510.000 million-$520.000 million to $510.000 million-$520.000 million vs $515.698 million estimate.
benzinga.com Phreesia Q1 EPS $0.05, Inline, Sales $130.935M Beat $130.128M Estimate Phreesia (NYSE:PHR) reported quarterly earnings of $0.05 per share which met the analyst consensus estimate. This is a 171.43 percent increase over losses of $(0.07) per share from the same period…- benzinga.com Wells Fargo Downgrades Phreesia to Equal-Weight, Lowers Price Target to $9 Wells Fargo analyst Stan Berenshteyn downgrades Phreesia (NYSE:PHR) from Overweight to Equal-Weight and lowers the price target from $15 to $9.
- benzinga.com Barclays Downgrades Phreesia to Equal-Weight, Lowers Price Target to $10 Barclays analyst Glen Santangelo downgrades Phreesia (NYSE:PHR) from Overweight to Equal-Weight and lowers the price target from $24 to $10.
- benzinga.com Phreesia Implements Restructuring Plan, Eliminates ~220 Positions To Reduce Operating Expenses And Align Costs With Business Priorities; Expects Plan Costs To Be Immaterial And Incurred In Fiscal Year 2027 On May 7, 2026, Phreesia, Inc. (the "Company") implemented a restructuring plan intended to reduce operating expenses and better align the Company's cost structure with its current business…
- benzinga.com Keybanc Maintains Overweight on Phreesia, Lowers Price Target to $12 Keybanc analyst Brandon Nispel maintains Phreesia (NYSE:PHR) with a Overweight and lowers the price target from $15 to $12.
- benzinga.com Citigroup Downgrades Phreesia to Neutral, Lowers Price Target to $10 Citigroup analyst Daniel Grosslight downgrades Phreesia (NYSE:PHR) from Buy to Neutral and lowers the price target from $25 to $10.
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com JP Morgan Downgrades Phreesia to Neutral, Lowers Price Target to $16 JP Morgan analyst Alexei Gogolev downgrades Phreesia (NYSE:PHR) from Overweight to Neutral and lowers the price target from $24 to $16.